Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials

BACKGROUND: Several clinical trials have studied the effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on glycometabolism and cardiovascular risk factors since they were identified. Because of their cardiovascular benefits and efficacy in lowering glucose, GLP-1RAs are becoming increas...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xu, Huang, Kun, Zheng, Meijie, Duan, Junting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323665/
https://www.ncbi.nlm.nih.gov/pubmed/30616638
http://dx.doi.org/10.1186/s12902-018-0332-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323665/
https://www.ncbi.nlm.nih.gov/pubmed/30616638
http://dx.doi.org/10.1186/s12902-018-0332-5

Ejemplares similares